GyneFix330和MCu110宫内节育器比较的系统评估

目的:评价GyneFix330与MCu110宫内节育器(IUD)的有效性、副反应和续用情况。方法:通过电子和手工检索查阅1990年1月～2009年11月国内外发表的相关文献,按照循证医学的方法对纳入文献进行分析评价,Meta分析采用RevMan 4.2.10软件。结果:共纳入5篇正式发表的随机对照临床试验性文章。有效性方面,置器后12个月和24个月,GyneFix330组与MCu110组的带器妊娠率和脱落率均低于2.00/100妇女。GyneFix330的带器妊娠率低于MCu110,但差异无统计学意义。副反应方面,置器后6个月、12个月和24个月,两组副反应各项观察指标的发生率逐渐降低。置器后12个月内,GyneFix330组腰/腹痛的发生率显著低于MCu110组,白带增多、不规则出血的发生率显著高于MCu110组。续用情况方面,置器后24个月内,两组IUD因症取出率均不超过8.00/100妇女,续用率接近95.00/100妇女。GyneFix330组12个月因症取出率显著低于MCu110 IUD,24个月内两组续用率接近。结论:GyneFix330 IUD的临床应用效果略优于MCu110 IUD,但需长期大样本临床观察予以确证。

GyneFix IN与活性γ型宫内节育器临床应用的对比分析

目的:对比观察新型GyneFix IN与活性γ型宫内节育器(IUD)的避孕效果及副反应。方法:以自愿选择为原则,对210例放置GyneFix IN和230例放置活性γ型IUD的妇女进行12个月的临床效果观察。结果:使用12个月时GyneFix IN和活性γ型IUD的有效续用率分别为97.14%和97.39%,人流术后放置的有效续用率更高,分别为97.06%和98.33%,两组比较均无显著性差异(P均>0.05)。在副反应方面,GyneFix IN组的点滴出血发生率为8.57%,较活性γ型组的2.17%有显著性差异(P<0.05),而活性γ型组的腰腹痛发生率为5.21%,较GyneFix IN组的1.00%,有显著性差异(P<0.05)。结论:GyneFix IN和活性γ型I UD均有理想的避孕效果,人流术后即时放置亦都安全有效,但在副反应方面各有其特点。孕龄妇女可在知情自愿的基础上,根据自身需要做出合理的选择。

宫内节育器-GyneFix IN临床应用效果观察

目的 :观察宫内节育器 GyneFixIN临床应用效果。方法 :3 0 0例妇女随机分为两组 ,研究组放置Gyne FixIN ,对照组放置TCu2 2 0C ,并随访 2 4月 ,比较其副反应及续用率。结果 :两种宫内放置节育器 (intrauterinedevice ,IUD)续用率分别为 98%和 90 % ,两种IUD放置后第 1月 ,副反应发生率较高 ,GyneFixIN以出血为主 ,而TCu2 2 0C以出血和疼痛为主 ,两组比较无差异 ;3个月后 ,GyneFixIN副反应明显减少 ,随访 2年中无节育器脱落 ,疼痛和出血发生率明显低于TCu2 2 0C组 ,两组比较差异有显著性。结论 :GyneFixIN安全、避孕效果好 ,其独特的无支架设计大大降低了副作用和传统IUD的不适感 ,值得在临床上推广应用。

人工流产术后即放置GyneFix IN致美宫内节育器120例临床观察

目的观察人工流产术后即时放置GyneFix IN致美宫内节育器的临床使用性能。方法随机给240例健康已婚育龄妇女在人工流产术后即时放置两种不同宫内节育器,其中GyneFix IN致美IUD 120例,对照组放置GyneFix IN IUD 120例,在放置后的3、6、12个月进行随访观察。结果使用12个月时两组IUD妊娠率均为1.67%(p>0.05);脱落率分别为0.87%,2.50%,GyneFix IN致美组明显低于GyneFix INIUD组(p<0.01);GyneFix IN致美组无1例因症取出,而GyneFix IN IUD组因症取出率为2.50%,GyneFix IN致美组明显低于GyneFix IN IUD组,两组差异有显著性意义(p<0.01)。结论 GyneFix IN致美较GyneFix INIUD具有出血少,因症取出率低,不良反应少,避孕效果好,是目前较理想的适合人流后放置的宫内节育器。

3种宫内节育器GyneFix IN、TCu380A、TCu220C的临床应用效果观察

目的了解GyneFixIN宫内节育器的临床使用效果。方法随机给396例健康已婚育龄妇女放置3种不同宫内节育器,其中GyneFix IN IUD135例,TCu380A130例,对照组TCu220C131例,在放置后的3、12个月进行随访观察。结果使用12个月时3组IUD妊娠率分别为0.7%,0.8%,2.3%,GyneFixINIUD和TCu380A明显低于TCu220C(P<0.05);脱落率分别为0%,6.9%,8.4%,GyneFix IN明显低于TCu380A和TCu220C;因症取出率分别为0%,5.4%,5.3%,GyneFixIN明显低于其他2组差异有显著性意义(P<0.01)。结论GyneFixIN具有脱落率低,不良反应少,避孕效果好,是目前较理想的宫内节育器。

人工流产术后即时放置GyneFix IUD、MCu IUD和TCu220 IUD避孕效果分析

目的:评价新型宫内节育器(IUD)GyneFix IUD和MCu IUD及传统节育器TCu220IUD的避孕效果。方法:以人工流产术后志愿放置IUD的690例为对象,随机分为3组,分别于人工流产术后即时放置Gyne Fix IUD、MCu IUD和TCu220IUD。结果:GyneFix IUD,MCu IUD和TCu220IUD使用12个月带器妊娠率分别为0.48%、0.85%、3.75%,脱落率分别为0.93%、0.85%、2.92%,因症取出率分别为2.80%、3.81%、6.25%,续用率分别为95.80%,94.49%,87.08%,放置IUD后月经异常发生率分别为8.88%、5.93%、12.5%。结论:GyneFix IUD、MCu IUD和TCu220IUD避孕效果均较理想,但TCu220IUD可能是放置型号不易掌握,带器妊娠、脱落、月经异常发生率较两种新型IUD高。

GyneFix IN与r型、MLCu IUD的临床效果观察

目的:观察新型GyneFix IN宫内节育器(IUD)的临床效果。方法:将450例健康经产妇女随机分成3组,A组:GyneFix IN组148例;B组:r型IUD组152例;C组:MLCu IUD组150例由经过培训的专人于月经间期放置GyneFix INIUD及r型IUD、MLCu IUD于放器后3,6,12和24个月随访以生命表法统计3种IUD的效果。结果:GyneFix IN组使用2年妊娠率、脱落率、因症取出率及续用率分别为1.35%﹑2.03%、2.03%、94.59%。GyneFix INIUD组脱落率(2.03%)明显低于MLCu IUD组的10.67%(P<0.01)也低于r型IUD的3.95%但差异无显著性(P>0.05)。3种IUD续用率分别为94.59%、89.47%和83.33%GyneFix INIUD续用率高于MLCu IUD(P<0.01)。结论:GyneFix INIUD无支架﹑铜表面积大并有固定系统,由经过培训的专人放置具有脱落率低、续用率高、不良反应小的优点值得临床推广。

Using laparoscope to remove an ectopic intrauterine device in the anterior wall of urinary bladder:A case report

BACKGROUND An intrauterine device(IUD)is a contraceptive device placed in the uterine cavity and is a common contraceptive method for Chinese women.However,an IUD may cause complications due to placement time,intrauterine pressure and other factors.Ectopic IUDs are among the most serious complications.Ectopic IUDs are common in the myometrium and periuterine organs,and there are few reports of ectopic IUDs in the urinary bladder,especially in the anterior wall.CASE SUMMARY A 52-year-old woman was hospitalized due to a urinary bladder foreign body found via abdominal ultrasound and computed tomography(CT)examination.The patient had a 2-year history of recurrent abdominal distension and lower abdominal pain,accompanied by frequent urination,urgency,dysuria and other discomfort.Ultrasound examination revealed foreign bodies in the bladder cavity,with calculus on the surface of the foreign bodies.CT revealed a circular foreign body on the anterior wall of the urinary bladder,suggesting the possibility of an ectopic IUD.After laparoscopic exploration,an annular IUD was found in the anterior wall of urinary bladder,and an oval calculus with a diameter of approximately 2 cm was attached to the surface of the bladder cavity.The IUD and calculus were successfully and completely removed.The patient recovered well after surgery.CONCLUSION Abdominal ultrasound and CT are effective methods for detecting ectopic IUDs.The IUD is located in the urinary bladder and requires early surgical treatment.The choice of surgical method is determined by comprehensively considering the depth of the IUD in the bladder muscle layer,the situation of complicated calculus,the situation of intravesical inflammation and medical technology and equipment.

Vaginal Testosterone Propionate with Misoprostol Prior to Removal of Intrauterine Devices in Postmenopausal Women

Objective To explore and investigate a new treatment of releasing the risks and pain in removing intrauterine devices （IUD） from postmenopausal women. Methods Totally 240 postmenopausal women who needed to remove IUD were randomly divided into 3 groups. Group A （n =80） were preoperatively treated with 20 g/L vaginal testosterone propionate cod liver oil ointment （1 g/d） over a 2-week span of period, and vaginal misoprostol （200 μg） was one-time used at 2-3 h before operation. Group B （n =80） were treated with oral estradiol valerate （3 mg/d） from 7 d before operation. Other 80 women （group C） were treated with vaginal cod liver oil ointment （1 g/d） over a 2-week span of period before the operation day. The degree of cervical relaxation, operational difficulty, blood loss volume, the length of operation time and visual analogue scales （VAS） were evaluated, also the serum estradiol, testosterone and endometrial thickness were measured before and after medication. Results The degree of cervical relaxation, operational difficulty, blood loss, the length of operation time and VAS in group A were significantly better than those group C （P〈0.01）, whiles its blood loss volume was less than group B （P〈0.05） and there were no significant differences in serum estradiol, testosterone and endometrial thickness before and after medication. Conclusion Preoperative vaginal testosterone propionate combined with misoprostol would reduce the operational difficulties/risks and release the suffering of patients. The study may represent a safe and effective alternative to remove IUD in postmeno- pausal women.

Effects of Copper-Containing Intrauterine Devices on the Endometrium

The use of copper-containing intrauterine devices(Cu-IUDs)is a safe,effective,and long-term contraceptive method.Here,we review the effects of Cu-IUDs on subsequent pregnancy and the morphology,local coagulation function,sensitivity to estrogen and progesterone,cell proliferation,and immune response of the endometrium.Studies on the morphology of endometrium indicate that the use of Cu-IUDs can affect the number and binding capacity of estrogen and progesterone receptors in the endometrium and reduce the response of the endometrium to estrogen and progesterone.The use of Cu-IUDs can also affect the proliferation of endometrial cells,suggesting that the aseptic inflammation caused by Cu-IUDs may differ from chronic infectious or noninfectious inflammation;this highlights that the use of Cu-IUDs provides protection against endometrial proliferative diseases.The use of Cu-IUDs increases local endometrial angiogenesis,bleeding tendency,and fibrinolytic activity,which can result in prolonged menstruation or abnormal uterine bleeding.Additionally,the use of Cu-IUDs can cause the infiltration of numerous lymphocytes,monocytes,macrophages,and other inflammatory cells around the endometrial gland and changes in endometrial immune function,immune cell function,and the number and type of immune molecules.Cu-IUD-induced decidual injury significantly increases the invasiveness of trophoblasts,further affecting the aberrant expression of their growth-,angiogenesis-,and invasion-related factors and improving the formation of the placenta.Moreover,the endometrial damage caused by Cu-IUD placement before embryo transfer can improve both clinical pregnancy and live birth rates;however,specific changes in the immune system after Cu-IUD use as well as its effects on future pregnancies require further investigation.

Cytotoxicity of six copper-bearing intrauterine devices on Chinese hamster ovary cells: the influence of frame, shape and copper surface area

Objective To evaluate the cytotoxicity of six commonly used copper-bearing intrauterine devices （Cu-IUDs） on Chinese hamster ovary （CHO-K1） cells and to investigate the influence of frame, shape and copper surface area of Cu-IUDs on cell toxicity.Methods Cu-IUDs were incubated in 10% FBS-DMEM/F12 culture medium at 37 ℃ for 24 h. The extracts were analyzed by flame atomic absorption spectrometer and were then diluted into different concentrations with culture medium. Finally, cytotoxicity of these original and diluted extracts on CHO-K1 cells was detected by cell counting kit-8 （CCK-8） assay.Results The viabilities of cells treated with the original extracts of six Cu-IUDs （TCu220C bulb, TCu220C, GCu220, GCu300, Yuangong Cu270 and Yuangong Ⅱ- 300） were all below 10% and the cupric ion concentrations in these extracts were 28.22 mg/L, 31.80 mg/L, 92.80 mg/L, 99.74 mg/L, 114.90 mg/L and 119.20 mg/L, respectively. After these original extracts were diluted, significant differences in cytotoxicity were exhibited. IUDs with larger copper surface areas （GCu300 and Yuangong Ⅱ-300） showed more cytotoxicity than those with smaller areas （GCu220 and Yuangong Cu270） respectively; When different shapes of Cu-IUDs were compared, TCu220C bulb showed lower cytotoxicity than TCu220C, and GCu300 exhibited higher toxicity than Yuangong Ⅱ-300; TCu220C displayed significantly lower cytotoxicity than GCu220 due to their differences in frames.Conclusion We presented evidence on the cytotoxic effects of copper ions released from Cu-IUDs on CHO-K1 cells and found that shape, frame together with copper surface area of Cu-IUDs had obvious influence on the cytotoxicity.

Postpartum Intrauterine Device: Use and Follow-Up of Users in the Maternity Ward of the Ratoma Communal Medical Center in Conakry, Guinea

Objective: The aim of this study was to describe the use of the postpartum intrauterine device in the maternity ward of the Ratoma communal medical center in Conakry. Methods: This was a descriptive cross-sectional study carried out between July 1st 2015 and June 30 2016, i.e. a duration of one year. Results: A total of 551 patients received advice on various contraceptive methods. Most of this advice was given in the post-partum period (40.2%) and during antenatal care (39.1%). Of the patients advised, 87 (15.8%) used the intrauterine device. The majority of users (93%) were married and uneducated (63.2%), and 39.1% were poor. The majority (56.3%) of intra-uterine devices were inserted in the immediate post-partum period. The majority of women had no adverse events either during the first six weeks (n = 57;65.5%) or at 3rd months (n = 75;86.2%) or 6th months (n = 76;87.4%) after IUD insertion. Most users remained complication-free throughout the follow-up period (n = 76;87.4% at 6th weeks and 3rd months, and n = 77;88.5% at 6th months). The continuation rate was 89.7% at 6 weeks and 3rd months, and 87.4% at 6th months after insertion. The majority of users (87.0%) were satisfied with the care they received. Conclusion: This study showed very few complications among intrauterine device users, and high continuation and satisfaction rates. The intrauterine device is a long-acting, effective, reversible and safe contraceptive that can be used by most women for birth spacing in Guinea, where women do not regularly visit health facilities.

非意愿妊娠女性人工流产后放置吉妮致美IUD效果

目的:探讨非意愿妊娠女性人工流产后放置吉妮致美宫内节育器(IUD)效果.方法:以2021年7月-2022年7月在本院自愿要求人工流产术的未育女性213例,对实行流产后关爱干预,其中选择IUD避孕103例为观察组,未选择IUD避孕方法110例为对照组,问卷调查比较两组干预前后对人工流产危害的知信行,比较流产后性生活恢复时间,随访1年非意愿妊娠及其妊娠原因、人工流产情况.结果:干预前后两组对人工流产危害性知识理论认知、态度信念、行为能力评分均提升(P<0.05),但两组间无差异;干预后观察组性生活恢复时间(3.7±0.1月)晚于对照组(3.2±0.9月),非意愿妊娠发生(8例,7.8%)低于对照组(24例,21.8%)(P<0.05),两组人工流产(0.9%、1.9%)发生无差异,观察组非意愿妊娠原因均为IUD脱落,对照组为避孕措施失败(11例,45.8%)和未避孕或避孕措施使用不正确(13例,54.2%).结论:吉妮致美IUD对降低人工流产后妇女非意愿妊娠有效,但需要重视IUD脱落率问题.

GyneFix IN与TCu 380A宫内节育器的随机比较性临床研究

目的观察新型ＧｙｎｅＦｉｘＩＮ宫内节育器（ＩＵＤ）的临床性能。方法采用随机对比性多中心临床研究方法，对６０７例健康经产妇女由经过培训的专人以随机方法于月经间期放置ＧｙｎｅＦｉｘＩＮＩＵＤ３２０例（ＧｙｎｅＦｉｘＩＮ组）及ＴＣｕ３８０ＡＩＵＤ３０５例（ＴＣｕ３８０Ａ组），于放器后１、３、６和１２个月随访，以生命表法统计两种ＩＵＤ的终止情况。结果ＧｙｎｅＦｉＸＩＮ组使用１年无妊娠发生，脱落和因症取出率分别为每百妇女２６７和１０２，与ＩＵＤ使用有关的终止率为每百妇女３６６，明显低于ＴＣｕ３８０Ａ组的每百妇女７８８（Ｐ＜００５）。ＧｙｎｅＦｉｘＩＮ组疼痛的主诉率也低于ＴＣｕ３８０Ａ组。结论此种无支架、铜表面积大并有固定系统的ＩＵＤ，由经过培训的人员放置，具有低脱落率和改善疼痛副反应的特点，有推广前景。

不同非手术治疗方案在子宫腺肌病中的临床效果分析

目的探讨不同非手术治疗方案在子宫腺肌病中的临床效果。方法回顾性分析非手术治疗子宫腺肌病患者临床资料130例,根据主治医师及患者选择治疗方案分为A组(曼月乐组,50例)、B组[促性腺激素释放激素激动剂(GnRHa)+曼月乐组,50例]和C组(地诺孕素组,30例)。观察各组治疗前与治疗后不同时间的子宫体积变化、月经量、痛经症状缓解情况、不良反应发生率及复发率等,评估临床治疗效果。结果治疗后各时间点子宫体积B组均小于A组,A组均小于C组,差异有统计学意义(P<0.05)。治疗后各时间点VAS评分C组均小于A组,差异有统计学意义(P<0.05);治疗后3个月、6个月痛经VAS评分、PBAC评分B组小于A组,差异具有统计学意义(P<0.05);治疗后6个月月经量评分C组小于B组,差异有统计学意义(P<0.05);治疗后12个月、24个月PBAC评分C组小于A组,差异有统计学意义(P<0.05)。不规则流血发生情况C组与A组差异无统计学意义(P>0.05)。结论3组治疗均可以缓解临床症状,但以GnRHa+曼月乐效果最佳。

无痛人流术后放置曼月乐与活性γ-宫内节育器的避孕效果比较

目的 探讨无痛人流术后宫内放置曼月乐与活性γ-宫内节育器(γ-IUD)的临床效果比较。方法 选取2020年6月—2022年1月淄博市妇幼保健院收治的120例无痛人流手术后有避孕意愿的妇女作为研究对象。采用随机数字表法将其分为A、B组,每组60例。A组术后即刻宫内放置曼月乐避孕,B组术后即刻宫内放置活性γ-IUD避孕。对比两组妇女不同时间的宫内节育器续用情况、月经周期变化、性生活质量、并发症发生率差异。结果 术后6个月,A组与B组妇女的累积续用率分别为95.00%和98.33%,差异无统计学意义(χ^(2)=1.000,P=0.317)。术后12个月,A组与B组妇女的累积续用率为93.33%和96.67%,差异无统计学意义(χ^(2)=0.702,P=0.302)。A组与B组妇女术前、术后3个月的月经周期、行经时间、月经量及性欲、性唤起、性高潮、性心理、性行为、射精时间6个调查维度评分差值比较,差异均无统计学意义(P>0.05)。A组妇女术后总并发症发生率为23.33%,高于B组的8.33%(P <0.05)。结论 无痛人流术后宫内放置曼月乐与活性γ-IUD的宫内避孕效果、累积续用率、性生活情况差异不大,但是后者术后的并发症发生率更低,更推荐临床使用。

产后立即放置GyneFix^(TM)PP型宫内节育器对产褥期的影响

目的探讨产后立即放置ＧｙｎｅＦｉｘＴＭＰＰ型宫内节育器（ＧｙｎｅＦｉｘＴＭＰＰ－ＩＵＤ）对产后出血、血性恶露及产后子宫内膜炎的影响。方法以产后放置ＧｙｎｅＦｉｘＴＭＰＰ－ＩＵＤ者为放器组（１２６例），产后未放置宫内节育器（ＩＵＤ）者为对照组（１１８例），分别记录两组研究对象产时、产后２小时、产后２４小时的出血量、血性恶露持续时间及产后子宫内膜炎的发生率。结果与产后出血及产褥期感染有关的因素两组间差异均无显著性（Ｐ＞０．０５）；两组间的产时或术时出血量、产后２小时出血量及２４小时的出血总量、子宫内膜炎的发生率，差异亦无显著性（Ｐ＞０．０５），两组间的血性恶露持续时间差异有显著性（Ｐ＜０．０５）。结论ＧｙｎｅＦｉｘＴＭＰＰ－ＩＵＤ对产后出血及产褥期感染无明显影响，具有较好的安全性，是产后立即避孕的一种较好方法，对血性恶露持续时间的影响及产生原因有待进一步研究。

固定式与支架式宫内节育器的有效性、安全性和续用率比较

目的:观察固定式宫内节育器(IUD)在育龄女性中的安全性、有效性和续用情况。方法:以2022年1-6月使用国家免费IUD的育龄妇女为研究对象,随访置入后1、3个月的IUD避孕效果、不良反应和续用情况。多因素logistic回归分析有宫颈松弛、宫颈宽大、既往IUD脱落史、分娩后或人工流产后即时放置IUD等特征的“特殊人群”使用不同类型IUD对随访结局的影响。结果:纳入使用固定式或支架式IUD者分别为1060人和1589人,固定式IUD组中特殊人群535例(占50.5%),支架式式IUD组中特殊人群288例(占18.1%)。放置后3个月特殊人群中固定式IUD月经改变和白带异常的发生率较支架式IUD组低(16.8%比18.8%,3.0%比3.5%,均P<0.05),续用率较支架式IUD组高(97.7%比92.8%,P<0.001)。多因素logistic回归分析显示,在一般人群中,放置后1个月固定式IUD发生月经改变的风险相较于放置支架式IUD低(OR=0.62,95%CI0.45~0.85);放置后3个月固定式IUD组发生白带异常的风险均较低(一般人群OR=0.50,95%CI0.29~0.80;特殊人群OR=0.43,95%CI0.24~0.72);发生IUD脱落/异位的风险增加无统计学意义(一般人群OR=1.41,95%CI0.52~3.53;特殊人群OR=1.57,95%CI0.61~3.83)。结论:固定式IUD在白带异常和月经改变方面的表现较优于传统的支架式IUD;在一般人群和特殊人群中,固定式IUD均为一种安全有效的避孕方式。

子宫颈癌放疗后宫内节育器取出23例分析

目的探讨子宫颈癌放疗后宫内节育器(intrauterine device,IUD)取出的经验。方法2020年1月~2022年12月我科对23例子宫颈癌放疗后IUD在腹部超声引导宫腔镜下取出。对于阴道和(或)宫颈粘连,在腹部超声引导下,宫腔检查镜镜体喙部或弯钳钝性分离粘连,若镜体喙部难以分离粘连进入宫腔,在超声引导下探针探入宫腔,逐渐扩张宫颈管至6号扩宫棒,再次置入宫腔检查镜进入宫腔;对于宫颈挛缩明显且坚韧,宫颈钳无法钳夹宫颈,1-0可吸收缝合线缝扎阴道顶端挛缩的宫颈前唇和(或)后唇,助手牢固牵拉固定宫颈。结果4例阴道部分粘连及宫颈挛缩,10例仅宫颈挛缩,余9例未见阴道粘连及宫颈挛缩。宫腔镜下见宫颈管粘连3例,子宫内膜息肉2例,黏膜下子宫肌瘤1例,宫腔积脓2例,IUD嵌顿2例,其余13例为正常宫腔形态。23例腹部超声引导宫腔镜成功完整取出IUD(圆形12例,宫形6例,V形2例,Y形1例,T形1例,伞形1例),手术时间(19.2±10.9)min,均无宫腔假道形成、子宫穿孔、脏器损伤、阴道大量出血、经尿道前列腺电切综合征、感染、栓塞、休克等并发症发生。23例术后随访2~24个月,中位数12个月,1例继续同步放化疗,3例继续后装放疗,1例继续化疗,2例靶向治疗(远处转移),余16例定期复查恢复良好,无腹痛、发热及阴道出血等并发症发生。结论子宫颈癌放疗后如果癌灶大小及部位不影响IUD取出,应尽早取出,腹部超声引导宫腔镜检查在宫颈癌放疗后IUD取出中具有一定的安全性及可行性。

宫腔镜取环术用于宫内节育环嵌顿的临床效果观察

目的探讨对宫内节育环嵌顿采用宫腔镜取环术治疗的临床效果。方法60例宫内节育环嵌顿患者,随机分为对照组和观察组,每组30例。对照组采用常规取环术治疗,观察组采用宫腔镜取环术治疗。比较两组手术指标以及取环情况、并发症发生率。结果观察组手术时间(18.61±4.57)min、取环时间(8.12±1.53)min均短于对照组的(31.44±7.25)、(10.33±2.10)min,阴道出血量(9.76±2.10)ml少于对照组的(16.25±2.43)ml(P<0.05)。观察组取环成功率96.67%高于对照组的70.00%(P<0.05)。观察组并发症发生率6.67%低于对照组的36.67%(P<0.05)。结论对宫内节育环嵌顿患者采用宫腔镜取环术治疗较常规取环术操作简单、效率高,对患者损伤小,能够提高取环成功率,可降低术后并发症发生风险,值得推广。